About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Annals of Hepatology
›
Top Articles
Annals of Hepatology
Hepatology
2.8
(top 6%)
Impact Factor
3.2
(top 6%)
extended IF
64
(top 6%)
H-Index
577
authors
3.1K
papers
30.4K
citations
3.5K
citing journals
17.2K
citing authors
Most Cited Articles of Annals of Hepatology
Title
Year
Citations
Prevalence of non-alcoholic fatty liver disease: population based study
2007
223
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
2009
196
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
2013
178
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis
2013
142
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens
2010
142
The importance of redox state in liver damage
2004
139
Prevalence of non-alcoholic fatty liver disease: population based study
2007
128
Bile Acid Physiology
2017
127
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
2011
123
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
2008
123
Gut microbiota and nonalcoholic fatty liver disease
2012
115
Liver fibrosis and inflammation. A review
2003
114
S-adenosylmethionine metabolism and liver disease
2013
112
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
2009
109
Metabolic syndrome and non-alcoholic fatty liver disease
2009
107
Cholestasis: human disease and experimental animal models
2003
105
Biliary secretion and excretion in health and disease: Current concepts
2007
101
The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes
2017
97
Hepatocellular carcinoma. An overview
2006
97
Dipeptidyl peptidase IV (DDP IV) in NASH patients
2007
95
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
2013
94
Kava hepatotoxicity. A clinical review
2010
93
Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress
2009
93
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport
2017
90
NASH and cryptogenic cirrhosis: A histological analysis
2009
89
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.